[Current treatment options for myelodysplastic syndromes]

Dtsch Med Wochenschr. 2010 Sep;135(38):1863-9. doi: 10.1055/s-0030-1263328. Epub 2010 Sep 14.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Azacitidine / therapeutic use
  • Blood Transfusion*
  • Bone Marrow Transplantation*
  • Chelation Therapy
  • Chromosome Deletion
  • Chromosomes, Human, Pair 5 / genetics
  • Female
  • Humans
  • Iron Overload / etiology
  • Iron Overload / therapy
  • Lenalidomide
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / therapy
  • Long-Term Care
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / genetics
  • Myelodysplastic Syndromes / therapy*
  • Palliative Care
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide
  • Azacitidine